Thrivent Financial for Lutherans’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.9M Buy
499,167
+265,847
+114% +$11.6M 0.05% 397
2025
Q4
$9.02M Buy
233,320
+22,015
+10% +$840K 0.02% 709
2025
Q3
$7.46M Sell
211,305
-33,948
-14% -$1.23M 0.01% 714
2025
Q2
$8.84M Sell
245,253
-230,572
-48% -$7.64M 0.02% 601
2025
Q1
$14.8M Hold
475,825
0.03% 460
2024
Q4
$12.1M Buy
475,825
+132,675
+39% +$3.52M 0.02% 599
2024
Q3
$9.71M Buy
343,150
+168,905
+97% +$4.68M 0.02% 686
2024
Q2
$4.59M Buy
174,245
+154,408
+778% +$4.28M 0.01% 933
2024
Q1
$602K Hold
19,837
﹤0.01% 2158
2023
Q4
$557K Sell
19,837
-1,740
-8% -$47.8K ﹤0.01% 2168
2023
Q3
$585K Sell
21,577
-2,640
-11% -$78.4K ﹤0.01% 2059
2023
Q2
$744K Buy
+24,217
New +$820K ﹤0.01% 1986

Other funds holding RPRX